Literature DB >> 18448013

[Cardiovascular risk factors in chronic obstructive pulmonary disease: results of the ARCE study].

Pilar de Lucas-Ramos1, José Luis Izquierdo-Alonso, José Miguel Rodríguez-González Moro, José María Bellón-Cano, Julio Ancochea-Bermúdez, Myrian Calle-Rubio, Eduardo Calvo-Corbella, Jesús Molina-París, Esteban Pérez-Rodríguez, Sonia Pons.   

Abstract

OBJECTIVE: Cardiovascular disease is a common cause of death in patients with chronic obstructive pulmonary disease (COPD). It is not clear whether the high cardiovascular comorbidity is due to an increase in traditional risk factors or whether, in contrast, COPD can be considered an independent risk factor. The aim of this study was to analyze the prevalence of risk factors and cardiovascular comorbidity in a community-based population treated for COPD. PATIENTS AND METHODS: This was a concurrent multicenter, cross-sectional study that included 572 patients with confirmed diagnosis of COPD. Information on cardiovascular risk factors and comorbidity was collected by extracting data from the medical records of the participating center.
RESULTS: The mean (SD) forced expiratory volume in 1 second (FEV1) was 53.7% (16.85%) of predicted and the ratio of FEV1 to forced vital capacity was 57.9% (10.9%). Hypertension was reported in 53%, obesity in 27%, dyslipidemia in 26%, and diabetes in 23% of the patients. The prevalence of risk factors was not related to disease severity, but there was a trend towards an association with age. In the study group, 16.4% had ischemic heart disease, 7% cerebrovascular disease, and 17% peripheral vascular disease. Cardiovascular disease was not associated with COPD severity, but such an association was reported for age and traditional risk factors.
CONCLUSIONS: Cardiovascular risk factors are highly prevalent in patients with COPD. The prevalence of cardiovascular and cerebrovascular disease exceeds that reported in the general population. No relationship was found between the severity of airflow obstruction and the presence of cardiovascular comorbidity.

Entities:  

Mesh:

Year:  2008        PMID: 18448013     DOI: 10.1016/s1579-2129(08)60037-3

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  8 in total

1.  Chronic obstructive pulmonary disease as a cardiovascular risk factor. Results of a case-control study (CONSISTE study).

Authors:  Pilar de Lucas-Ramos; Jose Luis Izquierdo-Alonso; Jose Miguel Rodriguez-Gonzalez Moro; Jesus Fernandez Frances; Paz Vaquero Lozano; Jose M Bellón-Cano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-10-01

2.  Lack of association of ischemic heart disease with COPD when taking into account classical cardiovascular risk factors.

Authors:  José Luis Izquierdo; Arturo Martínez; Elizabet Guzmán; Pilar de Lucas; José Miguel Rodríguez
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-11-08

3.  Coronary artery calcification, epicardial fat burden, and cardiovascular events in chronic obstructive pulmonary disease.

Authors:  Thomas Gaisl; Christian Schlatzer; Esther I Schwarz; Mathias Possner; Julia Stehli; Noriane A Sievi; Christian F Clarenbach; Damini Dey; Piotr J Slomka; Philipp A Kaufmann; Malcolm Kohler
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

4.  Impact of Comorbid Ischemic Heart Disease on Short-Term Outcomes of Patients Hospitalized for Acute Exacerbations of COPD.

Authors:  Masoud Aliyali; Hossein Mehravaran; Siavash Abedi; Ali Sharifpour; Jamshid Yazdani Cherati
Journal:  Tanaffos       Date:  2015

5.  Ischemic heart disease among subjects with and without chronic obstructive pulmonary disease--ECG-findings in a population-based cohort study.

Authors:  Ulf Nilsson; Bengt Johansson; Berne Eriksson; Anders Blomberg; Bo Lundbäck; Anne Lindberg
Journal:  BMC Pulm Med       Date:  2015-12-04       Impact factor: 3.317

6.  Management of the COPD Patient with Comorbidities: An Experts Recommendation Document.

Authors:  Jesús Recio Iglesias; Jesús Díez-Manglano; Francisco López García; José Antonio Díaz Peromingo; Pere Almagro; José Manuel Varela Aguilar
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-05-07

Review 7.  β-blockade: benefits beyond blood pressure reduction?

Authors:  John R Cockcroft; Michala E Pedersen
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-11-11       Impact factor: 3.738

8.  Comorbidity in patients with chronic obstructive pulmonary disease in family practice: a cross sectional study.

Authors:  Luis García-Olmos; Angel Alberquilla; Victoria Ayala; Pilar García-Sagredo; Leticia Morales; Montserrat Carmona; María José de Tena-Dávila; Mario Pascual; Adolfo Muñoz; Carlos H Salvador; Jose L Monteagudo
Journal:  BMC Fam Pract       Date:  2013-01-16       Impact factor: 2.497

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.